» Articles » PMID: 36232144

Mortality Related to Chronic Obstructive Pulmonary Disease During the COVID-19 Pandemic: An Analysis of Multiple Causes of Death Through Different Epidemic Waves in Veneto, Italy

Overview
Publisher MDPI
Date 2022 Oct 14
PMID 36232144
Authors
Affiliations
Soon will be listed here.
Abstract

Mortality related to chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic is possibly underestimated by sparse available data. The study aimed to assess the impact of the pandemic on COPD-related mortality by means of time series analyses of causes of death data. We analyzed the death certificates of residents in Veneto (Italy) aged ≥40 years from 2008 to 2020. The age-standardized rates were computed for COPD as the underlying cause of death (UCOD) and as any mention in death certificates (multiple cause of death-MCOD). The annual percent change (APC) in the rates was estimated for the pre-pandemic period. Excess COPD-related mortality in 2020 was estimated by means of Seasonal Autoregressive Integrated Moving Average models. Overall, COPD was mentioned in 7.2% (43,780) of all deaths. From 2008 to 2019, the APC for COPD-related mortality was -4.9% (95% CI -5.5%, -4.2%) in men and -3.1% in women (95% CI -3.8%, -2.5%). In 2020 compared to the 2018-2019 average, the number of deaths from COPD (UCOD) declined by 8%, while COPD-related deaths (MCOD) increased by 14% (95% CI 10-18%), with peaks corresponding to the COVID-19 epidemic waves. Time series analyses confirmed that in 2020, COPD-related mortality increased by 16%. Patients with COPD experienced significant excess mortality during the first year of the pandemic. The decline in COPD mortality as the UCOD is explained by COVID-19 acting as a competing cause, highlighting how an MCOD approach is needed.

Citing Articles

Sensitivity of major chronic diseases and patients of different ages to the collapse of the healthcare system during the COVID-19 pandemic in China.

Qamar A, Hui L Medicine (Baltimore). 2024; 103(48):e40730.

PMID: 39612440 PMC: 11608673. DOI: 10.1097/MD.0000000000040730.


Unrecognised COVID-19 deaths in central Europe: The importance of cause-of-death certification for the COVID-19 burden assessment.

Fihel A, Janicka A, Buschner A, Ustinaviciene R, Trakiene A PLoS One. 2024; 19(7):e0307194.

PMID: 39012883 PMC: 11251637. DOI: 10.1371/journal.pone.0307194.


Impact of COVID-19 Pandemic on Chronic Obstructive Pulmonary Disease Healthcare Use, Exacerbations, and Mortality: A Population Study.

Lam G, Wen C, Ronksley P, Bakal J, Bhutani M, Soril L Ann Am Thorac Soc. 2024; 21(9):1281-1288.

PMID: 38820253 PMC: 11376357. DOI: 10.1513/AnnalsATS.202312-1078OC.


Altered Mortality From Selected Non-communicable Diseases During the COVID-19 Pandemic in Germany in 2020 and 2021.

Baumert J, Scheidt-Nave C, Steppuhn H, Tetzlaff F, Kraywinkel K, An der Heiden M Dtsch Arztebl Int. 2024; 121(4):135-136.

PMID: 38518297 PMC: 11019757. DOI: 10.3238/arztebl.m2023.0262.


Comparison of Azvudine and Nirmatrelvir/Ritonavir and Combined Use in Patients with COVID-19.

Hu C, Cui W, Lei Y, Tang Y, Zhang Y, Su Q Infect Drug Resist. 2023; 16:7797-7808.

PMID: 38148771 PMC: 10750493. DOI: 10.2147/IDR.S433186.


References
1.
Luck A, Preston S, Elo I, Stokes A . The unequal burden of the Covid-19 pandemic: Capturing racial/ethnic disparities in US cause-specific mortality. SSM Popul Health. 2021; 17:101012. PMC: 8697426. DOI: 10.1016/j.ssmph.2021.101012. View

2.
Mannino D, Brown C, Giovino G . Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med. 1997; 156(3 Pt 1):814-8. DOI: 10.1164/ajrccm.156.3.9702026. View

3.
Jensen H, Godtfredsen N, Lange P, Vestbo J . Potential misclassification of causes of death from COPD. Eur Respir J. 2006; 28(4):781-5. DOI: 10.1183/09031936.06.00152205. View

4.
Lopez-Campos J, Ruiz-Ramos M, Soriano J . Mortality trends in chronic obstructive pulmonary disease in Europe, 1994-2010: a joinpoint regression analysis. Lancet Respir Med. 2014; 2(1):54-62. DOI: 10.1016/S2213-2600(13)70232-7. View

5.
Pardhan S, Wood S, Vaughan M, Trott M . The Risk of COVID-19 Related Hospitalsation, Intensive Care Unit Admission and Mortality in People With Underlying Asthma or COPD: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2021; 8:668808. PMC: 8242585. DOI: 10.3389/fmed.2021.668808. View